Search Results - "Magee, Diana"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Association of Surgeon-Patient Sex Concordance With Postoperative Outcomes by Wallis, Christopher J D, Jerath, Angela, Coburn, Natalie, Klaassen, Zachary, Luckenbaugh, Amy N, Magee, Diana E, Hird, Amanda E, Armstrong, Kathleen, Ravi, Bheeshma, Esnaola, Nestor F, Guzman, Jonathan C A, Bass, Barbara, Detsky, Allan S, Satkunasivam, Raj

    Published in JAMA surgery (01-02-2022)
    “…Surgeon sex is associated with differential postoperative outcomes, though the mechanism remains unclear. Sex concordance of surgeons and patients may…”
    Get more information
    Journal Article
  5. 5

    The role of cytoreductive nephrectomy in the immuno-oncological therapy era by Magee, Diana E., Helstrom, Emma, Kutikov, Alexander

    Published in Current opinion in urology (01-03-2023)
    “…Cytoreductive nephrectomy has had a variable role in the management of metastatic renal cell carcinoma (RCC) through the different systemic therapy eras…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Sequential intravesical gemcitabine-docetaxel vs. bacillus Calmette-Guerin (BCG) in the treatment of non-muscle invasive bladder cancer: A preliminary cost-effectiveness analysis by Bukavina, Laura, Bell, Spencer, Packiam, Vignesh T., Smaldone, Marc, Abbosh, Philip, Uzzo, Robert, Kutikov, Alexander, Correa, Andres F., Magee, Diana E.

    Published in Urologic oncology (01-09-2023)
    “…•A cost-effectiveness model was developed to compare gemcitabine-docetaxel to bacillus Calmette-Guérin (BCG).•Intravesical gemcitabine-docetaxel was less…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Neoadjuvant Versus Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Microsimulation Model by Hird, Amanda E., Magee, Diana E., Cheung, Douglas C., Sander, Beate, Sridhar, Srikala, Nam, Robert K., Kulkarni, Girish S.

    Published in Clinical genitourinary cancer (01-04-2021)
    “…Upper tract urothelial carcinoma (UTUC) is clinically understudied, and there are no definitive recommendations regarding timing of perioperative chemotherapy…”
    Get full text
    Journal Article
  15. 15

    Cost of Bladder Cancer Care: A Single-center Comparison of Radical Cystectomy and Trimodal Therapy by Magee, Diana E, Cheung, Douglas C, Hird, Amanda E, Chung, Peter, Warde, Padraig, Catton, Charles, Berlin, Alejandro, Zlotta, Alexandre, Fleshner, Neil E, Kulkarni, Girish S

    Published in Urology practice (01-07-2023)
    “…Radical cystectomy and trimodal therapy are both accepted options in the management of muscle-invasive bladder cancer. As such, we sought to evaluate the…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Abiraterone vs. docetaxel for metastatic hormone-sensitive prostate cancer: A microsimulation model by Hird, Amanda E, Magee, Diana E, Cheung, Douglas C, Matta, Rano, Kulkarni, Girish S, Nam, Robert K

    Published in Canadian Urological Association journal (01-09-2020)
    “…Our aim was to determine whether androgen deprivation therapy (ADT) with abiraterone acetate (AA) or ADT with docetaxel chemotherapy (DC) resulted in improved…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Assessment of Secondary Sarcomas Among Patients With Cancer of the Abdomen or Pelvis Who Received Combinations of Surgery, Radiation, and Chemotherapy vs Surgery Alone by Hird, Amanda E, Magee, Diana E, Matta, Rano, Saskin, Refik, Dvorani, Erind, Kulkarni, Girish S, Kodama, Ronald, Herschorn, Sender, Narod, Steven A, Nam, Robert K

    Published in JAMA network open (01-10-2020)
    “…The association of radiation and chemotherapy with the development of secondary sarcoma is known, but the contemporary risk has not been well characterized for…”
    Get full text
    Journal Article
  20. 20